611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Cancer
Resources
Basic InformationLatest News
Health Tip: Protect Yourself Against Breast Cancer1 in 5 Young Women Who Tan Indoors Get AddictedFDA Approves 2nd Gene TherapyOverall Survival Up for Melanoma Brain MetastasesCooling Mitts, Socks May Ease a Major Chemo Side EffectFirefighters Exposed to Carcinogens Through the SkinMachine Learning Model Predicts Risk of Upgrade to Breast CAWeight-Loss Surgery May Curb Risk for Certain CancersCould 'AI' Become a Partner in Breast Cancer Care?Breast Cancer More Lethal for Blacks Than WhitesIncrease in Rate of Breast Reconstruction for MastectomyWith Skin Cancer Surgery, Insurance MattersU.S. Filipinos Have Higher Thyroid Cancer MortalityNeed Cancer Screening? Where You Work MattersMore Women Choose Breast Reconstruction After MastectomyGenetic Variant Tied to Prostate Cancer OutcomesPrimary, Pulmonary Providers Endorse Lung CA ScreeningHow to Talk to Someone With CancerHealth Tip: Food Safety for People With CancerBreast Cancer Screenings Still Best for Early DetectionNew Tool IDs Mortality Risk After Bladder Cancer SurgeryStart Skin Cancer Prevention Early, Health Experts SayNegative Margins, Lymph Node Yields Predict SurvivalDouble Mastectomy May Mean a Hit to the PaycheckMost Cancer Drugs Approved in Europe Show No Survival BenefitLiver Cancer Remains a Major Public Health Burden GloballyInsurance Type Linked to Surgery Delay in MelanomaProvider Advice Impacts Breast Cancer Prevention DecisionsNewer Drug May Prolong Lymphoma RemissionSmoking Cessation Support Less Likely for Cancer PatientsHow Breast Cancer Gene Mutations Raise Risk of TumorsHealth Tip: Screening for Lung CancerOverall Breast Cancer Incidence Up for Some in 2005-2014Obesity Linked to 13 Types of CancerBreast Cancer's Decline May Have Saved 322,000 LivesLegal Cannabis Use Common Among Cancer PatientsUpper Abdominal Cancer Resections Up in OctogenariansVerzenio Approved for Advanced Breast CancerCheckpoint Inhibitors No Less Safe With RadiationAccurate Lung Cancer Staging Depends on Quality Nodal ExamHealth Tip: Recognizing Prostate CancerPropranolol Use Inversely Linked to Melanoma RecurrenceASTRO: SBRT Prolongs Survival in Non-Small-Cell Lung CancerASTRO: Patient Experience of Radiation Better Than ExpectedCentral Neck Dissection Underused in Some Thyroid CAAdding Drug to Standard Care May Prolong Lymphoma SurvivalCancer Risk Up for RA Patients With Venous ThromboembolismFewer Uninsured Cancer Patients After Medicaid ExpansionRadiation and Chemotherapy Together Boost Lung Cancer SurvivalAdjuvant Chemo Beneficial in Advanced Gastroesophageal CA
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Primary, Pulmonary Providers Endorse Lung CA Screening


HealthDay News
Updated: Oct 12th 2017

new article illustration

THURSDAY, Oct. 12, 2017 (HealthDay News) -- Primary care clinicians and pulmonologists endorse lung cancer screening (LCS), but there are limitations in their knowledge of screening components, according to a study published online Sept. 21 in the Annals of the American Thoracic Society.

Matthew Triplette, M.D., M.P.H., from the University of Washington in Seattle, and colleagues conducted an electronic survey of primary care and pulmonary providers to examine knowledge, beliefs, attitudes, barriers, and facilitators related to LCS. There were 196 participants; 80 percent of them were primary care clinicians, 19 percent were pulmonologists, and 1 percent were others.

The researchers found that 74 percent of participants endorsed the effectiveness of LCS; performance was suboptimal on knowledge-based assessments of screening eligibility, documentation, and nodule management. Key barriers included inadequate time and staffing (both 36 percent), and not addressing screening because patients had too many other illnesses (38 percent). Decision aids, used at the point-of-referral, were important clinical facilitators of LCS (51 percent) and facilitators of provider knowledge (59 percent). Several differences were seen by provider specialty, including primary care clinicians more often reporting time constraints and their patients having too many other illnesses to address screening.

"Providers endorsed the benefits of LCS, but there are limitations in provider knowledge of key screening components," the authors write.

Abstract
Full Text (subscription or payment may be required)